Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
3
×
life sciences
national blog main
clinical trials
europe blog main
fda
new york blog main
san francisco blog main
accent therapeutics
aducanumab
alzheimer's disease
amblyotech
asklepios biopharmaceutical
bioeurope
biogen
biomarin pharmaceutical
black diamond therapeutics
bladder cancer
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brainvectis
c. greg guyer
cancer drugs
cara therapeutics
codiak biosciences
cutaneous t-cell lymphoma
deciphera pharmaceuticals
deerfield management
detroit blog main
detroit top stories
drug development
drug discovery
eli lilly
endometral cancer
esperion
What
ipo
3
×
medicines
new
3
×
activity
approvals
based
begin
bio
biogen
biosciences
biotech
bio’s
black
brings
bubbles
cancer
cells
clamped
class
clinic
clinical
codiak
companies
covid
delays
developing
diamond
drug
economic
eluded
exosome
exosomes
fast
fda
formed
fund
hopes
including
isn’t
lead
Language
unset
3
×
Current search:
new
×
cancer
×
ipo
×
unset
×
@xconomy.com
3 years ago
Codiak Bio’s IPO Brings In $82M as Exosome Clinical Trials Begin
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic